GE Healthcare Makes Strategic Investment in AliveCor
AliveCor, an FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare.
Stay updated with breaking news from Tom Westrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AliveCor, an FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare.
The infusion of funds comes five months after GE Healthcare and AliveCor announced a partnership involving GE's Muse cardiac mapping system.
Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device.
GE Healthcare (NYSE:GE) and AliveCor announced today that they partnered to deliver electrocardiograms (ECGs) outside the hospital.
* Physicians accessing GE Healthcare's MUSE, a cardiac management system that connects to and integrates into the electronic medical record , can now view and interpret in MUSE ECGs taken by patients... | March 16, 2022